Sign Up | Log In | What is SocialPicks?

Repros Therapeutics Inc. (RPRX) Trade Now » Rate RPRX - Discuss RPRX - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

78.5%

Top:

100.0%

Rate RPRX:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

RPRX Analysis & Videos »

... View All >

RPRX: Bull or Bear?

Repros Therapeutics Inc. RPRX

62%

-90.07%
in 178 days

<> <> <> On 5/11/09, RPRX reported that its Proellex clinical programs are progressing well and according to plan. RPRX completed enrollment of its first Pivotal Phase 3 clinical trial (ZPU-303) for the chronic treatment of uterine fibroids and expect the first Pivotal Phase 3 clinical trial for the treatment of anemia associated with uterine fibroids (ZPU-301), to be fully enrolled mid-2009, which would then lead to top-line results in each study by the end of this year. RPRX expects top-line results from its other two complementary Pivotal Phase 3 studies, ZPU-302 (anemia) and ZPU-304 (chro...

Continue reading »

By Marian Filo (-24.55% risk: aggressive) 06/10/09

Comment

BioMedReports.com Extreme Trades: ACAD, ANPI, BSTC, RPRX, SNTS RPRX

73%

-90.21%
in 179 days

<> Below are four companies with market caps under $200 million (all financial data current as of 6/9/09 during intraday trading) which have pending FDA decisions and/or clinical trial results that may have a major impact on each of the underlying stock prices. A high risk/reward trading approach to consider for speculative traders is investing a small amount of money that you can afford to lose in a basket of stocks included in <font> Extreme FDA and Clinical Trial Calendar Trades </font> , which are highlighted in periodic articles at BioMedReports.com. Another approach is to simply bu...

Continue reading »

By Mike Havrilla (+1.04% risk: conservative) 06/09/09

Comment

... View All >

People Bullish on RPRX

devin

Analyst

N/A

4 mos ago

supratrader

Principal

N/A

4 mos ago

Marian Filo

Principal

62%

5 mos ago

Mike Havrilla

Principal

73%

5 mos ago

Rui Araújo

Associate

41%

about 1 year ago

People Bearish on RPRX

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.44%	381
2	Gerald Greene	18.14	+71.24%	211
3	stockmarketfunding.com	17.66	+25.60%	55
4	akiralegrand	13.47	+14.32%	62
5	anup2104	12.13	+74.22%	40

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
EBAY	eBay Inc
INTC	Intel Corp
ETFC	E*Trade Financial Corp
KO	The CocaCola Company
AIG	American International Group Inc.
AMD	Advanced Micro Devices Inc

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

DNDN		Cancer Vaccines: Investing Opportunities beyond Dendreon (NASDAQ: D... by Mike Havrilla
CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev

... more »

StreetInsider.com on RPRX

Form S-3 REPROS THERAPEUTICS INC.

Form SC 13D/A REPROS THERAPEUTICS INC. Filed by: Efficacy Capital, Ltd.

Form 4 REPROS THERAPEUTICS INC. For: Nov 30 Filed by: Lappe Mark

Form 4 REPROS THERAPEUTICS INC. For: Nov 19 Filed by: Lappe Mark

Form 4 REPROS THERAPEUTICS INC. For: Nov 12 Filed by: Thompson Jaye

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About Repros Therapeutics Inc. - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.